<DOC>
	<DOC>NCT03035734</DOC>
	<brief_summary>Open label, randomized, 4-period crossover study with single doses of BMS-986141 given to healthy female subjects of non-childbearing potential and healthy males.</brief_summary>
	<brief_title>Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Healthy participants as determined by no significant deviations in normal medical and surgical history and assessments Body mass index 18.0 kg/m2 to 32.0 kg/m2 females must be of nonchildbearing potential known bleeding or coagulation disorders acute or chronic medical illness history of nausea or chronic diarrhea that lasts over 4 weeks history of periodontal disease or gingivitis which required treatment other exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>